Demand for Patient Positioning Systems and Impact of COVID-19……..


The global patient positioning systems market is anticipated to reach USD 1.4 billion by 2025, according to a new report by Grand View Research, Inc., registering a 4.7% CAGR during the forecast period. This market is expected to witness lucrative growth during through 2025 owing to rising awareness about and surging expenditure on diagnostic procedures. In addition, increasing prevalence of cancer and rising geriatric population are expected to assist in market growth.
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
According to the National Cancer Institute, in 2016, there were 1,685,210 new cases of cancer diagnosed in U.S. and 14.1 million cases globally. The most common types of cancer are breast cancer, prostate cancer, and colon and rectum cancer. This steady increase in disease prevalence acts as a driver for R&D investments in the industry. Increase in innovation has resulted in improved efficiency and accuracy of these systems in cancer therapy. These products keep patients immobile yet comfortable during radiotherapy. This is anticipated to supplement industry growth.
Rising expenditure on diagnostics procedures has been a strong force driving demand in the market. According to a research published by NCBI, majority oncologists and cardiologists in U.S. and Germany prescribe diagnostics tests and choose a treatment plan only after studying test results. Thus, demand for diagnostics tests is increasing globally.
To Request Sample Copy of this report, click the link:
Further key findings from the study suggest:
·         By product, the tables segment held a lucrative market share in 2016, owing to increasing prevalence of cancer and rising number of surgeries performed
·         In terms of application, the surgery segment is expected to account for the dominant market share on account of rising incidence of cancer, globally
·         By end use, the ambulatory segment is expected to register the highest growth over the forecast period owning to increase in precision of minimally invasive technologies
·         North America is projected to dominate the patient positioning systems market over the forecast period due to presence of a large number of diagnostic centers
·         Some of the key players in the patient positioning systems market are Medtronic; Hill-Rom Holdings, Inc.; Stryker Corporation; Medline Industries; Skytron, LLC; OPT SurgiSystems Srl; SchureMed; Smith & Nephew; STERIS plc; and Leoni.
The global patient positioning systems market size was valued at USD 942.8 million in 2016 and is expected to expand at a CAGR of 4.7% during the forecast period. Growing geriatric population, increasing prevalence of cancer, rising awareness among patient population, and surging expenditure on diagnostic procedures are expected to boost the patient positioning systems market during the forecast period.
Technological advancements in sensors, such as optic fiber technology, cancer tracking sensors, and MEMS sensors, is expected to fuel market growth. These systems help keep patients in a comfortable and stable position during radiotherapy as well as treatment delivery. The growth of this market is further supplemented by increasing prevalence of cancer.
According to the World Cancer Report published by the WHO, the prevalence of cancer is estimated to reach 15 million new cases per year by 2020. The National Cancer Institute estimated that 1,685,210 new cases of cancer may have been diagnosed in 2016 in U.S. alone. This steady increase in disease prevalence acts as a driver for R&D investment in the industry.
Increasing awareness about and rising expenditure on diagnostic procedures is also expected to increase the demand for patient positioning systems in the market. According to the National Health Services (NHS), there were 42.1 million diagnostics imaging tests performed in U.K. in the year 2016-2017. An increase of 3.6% was recorded in the number of diagnostic imagining tests performed when compared to the previous year. Additionally, there are many awareness campaigns regarding early cancer diagnosis such as the National Awareness and Early Diagnosis Initiative (NAEDI) in U.K. and Breast Cancer Now in U.S., which are expected to increase the demand for diagnostic imaging procedures. This, in turn, is expected to increase the demand for patient positioning systems.
Browse Press Release of this report:
The products analyzed in this study include tables and accessories. The tables segment is expected to dominate the market owing to increased demand and rising number of hospitals, ambulatory centers, and other settings such as specialty centers and diagnostics centers.
The tables segment is expected to retain its lead over the forecast period due to rising demand for efficient and accurate diagnostic imaging, which is creating growth opportunities for the segment.
The accessories segment is expected to witness the fastest growth in the market, owing to increasing number of patients undergoing different types of surgeries and diagnoses. There is a greater demand for diagnosis in developing countries such as India and China, which may drive sales of patient positioning systems over the forecast period.
Based on application, patient positioning systems are segmented into diagnostics/imaging, surgery, and others. The surgery segment held the largest share owing to increasing prevalence of chronic diseases such as cancer. Additionally, there is an increase in healthcare expenditure globally. This is anticipated to further supplement the growth of this application.
The diagnostics segment is estimated to grow at a lucrative rate over the forecast period, due to increasing expenditure on diagnostics/imaging, globally.Diagnostics tests represent more than 3.0% of the total healthcare spending. These tests also play a major role in a doctor’s decision-making process. Almost all cancer diagnoses are based on laboratory tests and their results.
Grand View Research has segmented the global patient positioning systems market on the basis of products, application, end use:
Patient Positioning Systems Product Outlook (Revenue, USD Million, 2014 - 2025)
·         Tables
·         Accessories
Patient Positioning Systems Application Outlook (Revenue, USD Million, 2014 - 2025)
·         Surgery
·         Diagnostics
·         Other
Patient Positioning Systems End-use Outlook (Revenue, USD Million, 2014 - 2025)
·         Hospital
·         Ambulatory Centers
·         Other
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


Comments

Popular posts from this blog

Foot Orthotic Insoles Market 2026: What Will Be Changes In Investment Ratio With Opportunity Analysis?? |Grand View Research, Inc.

A Look into Smokehouse Industry……Deep Analysis…..

A Look into Shapewear Industry……Deep Analysis…..